Comprehensive and efficient in vitro transcription process development platform
· Two mature mRNA drug substance platforms: co-transcriptional capping and post-transcription capping
· For mRNA of different lengths and GC content, the platform process can achieve a yield of 9.0-11.0 mg/mL IVT
· Advanced Oligo dT purification platform, with a variety of Oligo dT resins available
· Process development can be completed in 4 weeks, and process qualification and technology transfer can be completed in 2 weeks